Koss-Olinger Consulting’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.09M | Buy |
|
|||||
|
2025
Q1 | $3.54M | Buy |
|
|||||
|
2024
Q4 | $3.66M | Buy |
|
|||||
|
2024
Q3 | $1.36M | Hold |
|
|||||
|
2024
Q2 | $1.1M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $981K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $798K | Hold |
|
|||||
|
2023
Q1 | $695K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $525K | Hold |
|
|||||
|
2021
Q1 | $500K | Buy |
|